USPTO serial 79222476
BIOIS SYSTEM BIOLOGY INNOVATOR
Reviewed by CopyMark Law Group
Reg. 5598049Status 709
- Filing date
- Status date
- Registration date
- Nov 6, 2018
- Examiner
- ESTRADA, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOIS SYSTEM BIOLOGY INNOVATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents for immunization disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes | SECTION 71 - CANCELLED | — |
| 009 | DNA chips; optical scanners; downloadable computer programs for medical or veterinary diagnosis; biochips, namely, biochips for research or scientific purposes; biochip sensors; diagnostic apparatus, not for medical purposes, namely, for the detection of pathogens for laboratory or research use; cell chip inspectors, namely, inspection machines for the physical inspection of cell chips; magnetic agitators for laboratory use; laboratory centrifuges; physical and chemical laboratory apparatus and instruments, namely, laboratory apparatus and instruments for extracting nucleic acid; constant temperature incubators for laboratory use; chemistry apparatus and instruments, namely, laboratory glassware; operating system programs; apparatus and instruments for physics, namely, plastic, rubber and elastomer closures, seals and stoppers for laboratory bottles; apparatus for automatic chromatography, namely, chromatography columns for laboratory use; dosage dispensers, namely, machines for dispensing pre-determined dosages of medication; diagnostic chips for inspecting blood plasma other than for medical use, namely, chips functioning as diagnostic apparatus for the detection of pathogens for laboratory use; diagnostic chips for analyzing blood plasma other than for medical use, namely, chips functioning as diagnostic apparatus for the detection of pathogens for laboratory use | SECTION 71 - CANCELLED | — |
| 010 | Cancer diagnosis apparatus, namely, diagnostic apparatus for medical purposes; medical body composition monitor; immunoassay apparatus for diagnostics, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; miniaturized sensors for use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis; medical apparatus and instruments, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments other than for dental purposes for medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; apparatus for use in medical analysis, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical genetic testing devices, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical genetic fragment analyzers; medical genetic analyzer; medical absorption analysis apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; DNA extraction and purification apparatus for medical purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; in vitro diagnostic devices, namely, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for DNA analysis other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for RNA analysis other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; medical apparatus and instruments for protein analysis other than for dental purposes, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins; gene and genetic testing apparatus, namely, medical devices and kits for measuring, monitoring, sampling, and analyzing nucleotides and proteins | SECTION 71 - CANCELLED | — |
| 042 | Research and development of DNA chips; structural and functional analysis of genomes; research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research, namely, medical research in the field of crude medicines; biochemical analysis; biochemical research; bacteriological research; inspection of foodstuffs for quality control; analysis of food ingredients, namely, research on food; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; research on the subject of pharmaceuticals; research in the field of gene analysis; genetic research, namely, scientific research in the field of genetics; medical product testing; research for medical products; clinical trials, namely, conducting clinical trials for others in the field of measuring, monitoring, sampling, and analyzing nucleotides and proteins | SECTION 71 - CANCELLED | — |
| 044 | Medical and health services relating to DNA, genetics and genetic testing; medical analysis services relating to the treatment of persons having cancer; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons, namely, diagnosis of cancer; RNA and DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; medical diagnostic services, namely, medical testing and analysis for diagnostic or treatment purposes in the field of cancer; medical testing services relating to the diagnosis and treatment of disease, namely, cancer; medical laboratory services for the analysis of blood samples taken from patients, namely, medical testing of blood | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIOIS SYSTEM BIOLOGY INNOVATOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 3, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 3, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 23, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 23, 2025 | C71T | CANCELLED SECTION 71 | — |
| Nov 6, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 11, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 11, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 6, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 21, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 17, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 1, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 1, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 1, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 5, 2018 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| May 4, 2018 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Mar 23, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 19, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 31, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 30, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 16, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |